These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32753240)

  • 1. Radiation therapy on primary tumour of synchronous metastatic head and neck squamous cell carcinomas.
    Tang É; Nguyen TV; Clatot F; Rambeau A; Johnson A; Sun XS; Tao Y; Thariat J
    Cancer Radiother; 2020 Oct; 24(6-7):559-566. PubMed ID: 32753240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional treatment of primary tumor in synchronous metastatic head and neck squamous cell carcinomas.
    Tang E; Schwartz B; Limkin E; Even C; Blanchard P; Haddy N; Gorphe P; Ferrand FR; Tao Y; Nguyen TV
    Acta Oncol; 2023 May; 62(5):465-472. PubMed ID: 37151099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy.
    Tonneau M; Nebbache R; Larnaudie A; Thureau S; Pointreau Y; Blanchard P; Thariat J
    Cancer Radiother; 2024 Feb; 28(1):83-92. PubMed ID: 37620212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma.
    Tang E; Lahmi L; Meillan N; Pietta G; Albert S; Maingon P
    Curr Oncol Rep; 2019 Nov; 21(11):102. PubMed ID: 31728650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study.
    Carsuzaa F; Thariat J; Gorphe P; Righini C; Cosmidis A; Thureau S; Roge M; De Mones E; Servagi-Vernat S; Tonnerre D; Morinière S; Dugas A; Malard O; Pasquier F; Vergez S; Salleron J; Dufour X
    Ann Surg Oncol; 2019 Oct; 26(11):3673-3680. PubMed ID: 31264120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo metastatic head and neck squamous cell carcinoma: Why does locoregional control "always" matter?
    Lorini L; Gili R; Salvestrini V; Morelli I; Smussi D; Petrelli F; Bonomo P; Bossi P
    Oral Oncol; 2024 May; 152():106768. PubMed ID: 38552469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.
    Rambeau A; Bastit V; Thureau S; Thariat J; Moldovan C; Roge M; Babin E; Gery B; Di Fiore F; Florescu C; Clatot F
    Oral Oncol; 2019 Jun; 93():46-51. PubMed ID: 31109695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].
    Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J;
    Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reirradiation of head and neck cancers].
    Doyen J; Lam Cham Kee D; Krebs L; Guigay J; Dassonville O; Peyrade F; Poissonnet G; Saâda-Bouzid E; Sudaka A; Bozec A; Bénézery K
    Cancer Radiother; 2017 Oct; 21(6-7):521-526. PubMed ID: 28826697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Nishimura A; Yokota T; Hamauchi S; Onozawa Y; Shirasu H; Kawabata T; Ogawa H; Onoe T; Iida Y; Mukaigawa T; Yasui H
    Int J Clin Oncol; 2021 Oct; 26(10):1822-1830. PubMed ID: 34152533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Oligometastatic Disease in Squamous Cell Carcinoma of the Head and Neck.
    Vincent AG; Wang W; Shokri T; Ducic Y
    Laryngoscope; 2021 May; 131(5):E1476-E1480. PubMed ID: 33044014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy.
    Dhouib F; Bertaut A; Maingon P; Siala W; Daoud J; Aubignac L; Lestrade L; Crehange G; Vulquin N
    Technol Cancer Res Treat; 2020; 19():1533033820905826. PubMed ID: 32484037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional control, progression-free survival and morbidity rates in N3 head and neck cancer patients with low primary tumour burden: A 301-patient study.
    Carsuzaa F; Dufour X; Gorphe P; Righini C; Cosmidis A; Rogé M; De Mones E; Servagi Vernat S; Tonnerre D; Morinière S; Dugas A; Malard O; Pasquier F; Vergez S; Schick U; Gérard M; Salleron J; Thariat J
    Clin Otolaryngol; 2020 Nov; 45(6):877-884. PubMed ID: 32729227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
    Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
    J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligometastasis in Head and Neck Squamous Cell Carcinoma.
    Moon DH; Sher DJ
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):803-811. PubMed ID: 35798219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reirradiation for head and neck squamous cell carcinoma: Indications and results].
    Biau J; Moreau J; Blanchard P; Thariat J; Miroir J; Lapeyre M
    Cancer Radiother; 2019 Oct; 23(6-7):559-564. PubMed ID: 31451359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of second primary gingival squamous cell carcinoma after radiotherapy.
    Fu X; Chen S; Chen W; Yang Z; Song M; Li H; Zhang H; Yao F; Su X; Liu T; Yang AK
    Oral Oncol; 2018 Sep; 84():20-24. PubMed ID: 30115471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of neck dissection before definitive radiation therapy for locoregionally advanced squamous cell carcinoma of the head and neck].
    Modesto A; Sarini J; Benlyazid A; Ouali M; Laprie A; Graff P; Vergez S; Uro-Coste E; Fauquet I; Delord JP; Rives M
    Cancer Radiother; 2016 Feb; 20(1):18-23. PubMed ID: 26749214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
    Bonomo P; Greto D; Desideri I; Loi M; Di Cataldo V; Orlandi E; Iacovelli NA; Becherini C; Visani L; Salvestrini V; Mariotti M; Livi L
    Oral Oncol; 2019 Jun; 93():1-7. PubMed ID: 31109688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.